Pfizer sets up global capability centre in India

NEW DELHI: Pfizer Inc launched the company’s first-ever dedicated commercial analytics centre in India, which is also the company's first global capability centre for international markets.

The 'Analytics Gateway' located in Mumbai is positioned to be a global capability centre (GCC) serving all of Pfizer’s international (ex-US) markets to bring analytics, and insight breakthroughs that will benefit patients, says a company statement.

The centre represents a significant milestone in Pfizer’s international commercial strategy and will play a pivotal role in driving the company’s growth across 140 international markets, utilizing cutting-edge data analytics, AI, and insights, it adds.

This comes even as several MNCs and pharma companies are shifting their India strategy from marketing and distribution, to setting up GCCs to support their international operations. India, dubbed as the GCC capital of the world, is reportedly expected to cross over $100 billion in GCC export revenue by 2029-30 financial year, up from $64.6 billion in 2023-24.